![Jin Zhong Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jin Zhong Zhang
Chief Executive Officer at Eluminex Biosciences (Suzhou) Ltd.
Jin Zhong Zhang active positions
Companies | Position | Start | End |
---|---|---|---|
Eluminex Biosciences (Suzhou) Ltd.
![]() Eluminex Biosciences (Suzhou) Ltd. BiotechnologyHealth Technology Eluminex Biosciences (Suzhou) Ltd. is a privately held biotechnology company located in Suzhou, China. Eluminex Biosciences is committed to developing innovative pharmaceuticals, drug delivery systems, and regenerative tissue for significant unmet vision-threatening or lifestyle limiting ophthalmic diseases in various markets. The Chinese company focuses on ophthalmology and recombinant human collagen technology, with a goal to become a leading healthcare company in developing irreversible loss of optical quality of the cornea due to disease or damage, diabetic macular edema, and wet age-related macular degeneration. The company was founded in 2020 by Jin Zhong Zhang, who has been the CEO since then. | Chief Executive Officer | 2019-12-31 | - |
Chairman | 2019-12-31 | - | |
Founder | 2019-12-31 | - |
Career history of Jin Zhong Zhang
Statistics
International
China | 2 |
Operational
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Eluminex Biosciences (Suzhou) Ltd.
![]() Eluminex Biosciences (Suzhou) Ltd. BiotechnologyHealth Technology Eluminex Biosciences (Suzhou) Ltd. is a privately held biotechnology company located in Suzhou, China. Eluminex Biosciences is committed to developing innovative pharmaceuticals, drug delivery systems, and regenerative tissue for significant unmet vision-threatening or lifestyle limiting ophthalmic diseases in various markets. The Chinese company focuses on ophthalmology and recombinant human collagen technology, with a goal to become a leading healthcare company in developing irreversible loss of optical quality of the cornea due to disease or damage, diabetic macular edema, and wet age-related macular degeneration. The company was founded in 2020 by Jin Zhong Zhang, who has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Jin Zhong Zhang
- Experience